Malignant epithelioid mesothelioma
MONDO:0005599A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic cells with an epithelioid appearance. In the majority of cases, the neoplastic epithelioid cells lack significant cytologic atypia; mitotic figures are infrequently seen. In a minority of cases, the neoplastic cells are poorly differentiated and there is evidence of nuclear atypia and increased mitotic activity.
Also known as: epithelial mesothelioma, epithelioid mesothelioma, epithelioid mesothelioma, malignant, epithelioid mesothelioma, malignant (morphologic abnormality), malignant epithelial mesothelioma
2741 clinical trials for this condition and its sub-types, 5 tagged with Malignant epithelioid mesothelioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Malignant epithelioid mesothelioma
-
Pleural epithelioid mesothelioma 8 trials
-
Could a Triple-Drug combo tame mesothelioma?
Disease control OngoingThis study tests whether adding the drug cediranib to standard chemotherapy (cisplatin and pemetrexed) can help people with malignant pleural mesothelioma, a rare and aggressive lung cancer. In the first phase, researchers found the safest dose of cediranib. In the second phase, …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug cocktail aims to boost mesothelioma surgery success
Disease control OngoingThis early-phase trial is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy (cisplatin and pemetrexed) before and after surgery can help people with resectable pleural mesothelioma. The study includes 28 participants with stage I-III disease. The…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC